Aurobindo obtains FDA approval for generic Pathocil
Dicloxacillin sodium capsules are indicated for the treatment of infections caused by penicillinase-producing staphylococci, which have demonstrated susceptibility to the drug.
Aurobindo has received the Food and Drug Administration’s blessing for dicloxacillin sodium capsules in dosage strengths of 250 mg and 500 mg.
The medication is the generic of Wyeth Ayerst’s Pathocil.
[Read more: Aurobindo obtains FDA approval for generic Colcrys]
Dicloxacillin sodium capsules are indicated for the treatment of infections caused by penicillinase-producing staphylococci, which have demonstrated susceptibility to the drug.
[Read more: Aurobindo obtains FDA OK for generic Lioresal]
Dicloxacillin sodium capsules have a market value of roughly $5.3 million for the 12 months ending July 2022, according to IQVIA.